Furthermore, they stated that the expression of miR-146a in individuals susceptible to diabetes, patients with T2D tolerating insulin therapy, high obesity/glycemia, and T2D patients with diabetic foot ulcers and nephropathy was reduced in serum but was not linked with cell functionality [41]. The gene discussed is INS; the disease is type 2 diabetes mellitus.